IGN-312

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIGN-312
Drug Alias Nameglycoengineered IGN-311 derived MAb (Aphton)anti-Lewis Y mAb (Igeneon)glycoengineered IGN-311 derived MAb (Igeneon)IGN-312
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIgeneon Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIgeneon Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A